However, when the E:T ratio was five times lower (0.1 effector T cells per 1 tumor cell), CD8-EGFR-GFP T cells were clearly more efficient killing B16-OVA cells with respect to CD8-GFP cells (Figure 3D, second graph). Here, CD8A is linked to neoplasm.